Galderma
Pure-play dermatology company spanning injectable aesthetics, dermatologic skincare and therapeutic dermatology.
Therapeutic areas
Selected products and programs
Linked curated drug profiles
Selected active clinical trials
Phase 3 · Not Yet Recruiting · Atopic Dermatitis
A Study to Characterize Human Skin Changes From Biostimulator Treatments Via Non-invasive ImagingNA · Recruiting · Volume Deficiency in the Mid-Face
A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal StagesNA · Recruiting · Cheek Wrinkles
Study to Evaluate the Safety of Retreatment With Restylane® Lyft With Lidocaine for Augmentation of the Chin RegionNA · Recruiting · Chin Augmentation
A Study of Nemolizumab for the Treatment of Adults With Systemic SclerosisPhase 2 · Recruiting · Systemic Sclerosis
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants Aged 6 to 23 Months With Moderate-to Severe Atopic DermatitisPhase 2 · Recruiting · Moderate-to-Severe Atopic Dermatitis
Selected patent records
Primary and company sources
Company and pipeline information can change. Verify material decisions against the linked primary sources.
Evidence & limits
Source: Open the source record
- Record identifier
- /companies/galderma/
- Event / action date
- Not separately retained
- Source update date
- Not separately retained
- Platform retrieval / processing date
- Not separately retained
What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.
Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.
Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.